Tags: Drug.

Atiprimod (INN codenamed SK&F106615) is a substance being studied in the treatment of certain multiple myelomas and other advanced cancers. It may block the growth of tumors and the growth of blood vessels from surrounding tissue to the tumor. This drug is also being developed by AnorMED as a potential treatment for rheumatoid arthritis and other autoimmune diseases. It was first developed by SmithKline Beecham (now part of GlaxoSmithKline) as a potential treatment for rheumatoid arthritis.

Atiprimod.svg
ATC prefix
none
CAS number
123018-47-3
FDA UNII code
MG7D3QD743
IUPAC name
3-(88-dipropyl-3-azaspiro[4.5]decan-3-yl)-NN- diethylpropan-1-amine
PubChem
129869

Loading...

This page contains content from the copyrighted Wikipedia article "Atiprimod"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.